Regulatory Information
HSA regulatory responsibility and product classification details
Regulatory Responsibility
Product Classification
Formulation Information
SOLUTION
**DOSAGE AND ADMINISTRATION** The recommended dose of ACULAR® ophthalmic solution is one drop (0.25 mg) four times a day for relief of ocular itching due to seasonal allergic conjunctivitis. For the treatment of postoperative inflammation in patients who have undergone cataract extraction, one drop of ACULAR® ophthalmic solution should be applied to the affected eye(s) four times daily beginning 24 hours after cataract surgery and continuing through the first 2 weeks of the postoperative period.
OPHTHALMIC
Medical Information
**INDICATIONS AND USAGE** ACULAR® ophthalmic solution is indicated for the temporary relief of ocular itching due to seasonal allergic conjunctivitis. ACULAR® is also indicated for the treatment of postoperative inflammation in patients who have undergone cataract extraction.
**CONTRAINDICATIONS** ACULAR® ophthalmic solution is contraindicated in patients with previously demonstrated hypersensitivity to any of the ingredients in the formulation.
S01BC05
ketorolac
Manufacturer Information
ABBVIE PTE. LTD.
ALLERGAN PHARMACEUTICALS IRELAND
Active Ingredients
Documents
Package Inserts
Acular Ophthalmic Solution PI.pdf
Approved: April 26, 2018